Baba Ramdev’s Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know

By: |
Updated: June 23, 2020 6:56 PM

Coronavirus-induced COVID-19 has caused a global pandemic, due to which the number of cases all over the world have reached nearly 90 lakh.

patanjali, coronavirus, coronavirus pandemic, coronavirus in India, coronavirus outbreak, coronavirus treatment, coronavirus medicine, coronavirus cure, coronavirus ayurveda cure, patanjali medicine for coronavirus, coronil, coronavirus medicine trials, coronavirus research, Patanjali yogpeeth, Baba Ramdev, Acharya BalkrishnaThe trial was conducted by Patanjali Ayurvedic Medicines.

Fighting Coronavirus pandemic: Patanjali’s Ayurvedic medicine launched! Yoga Guru Baba Ramdev’s Patanjali Ayurved has launched Coronil with “Coronakit”! As India continues to see a sharp increase in coronavirus cases every day, the quest for medicine and vaccine against the disease has picked up pace. All over the world, scientists and health authorities have been working tirelessly to come up with a treatment for COVID-19, which has wreaked havoc globally. Amidst this, the ayurvedic consumer goods company founded by Baba Ramdev has claimed that its medicine called Coronil can help in treating COVID-19. Patanjali Ayurved Limited MD Acharya Balkrishna had announced the launch on Twitter on Monday evening.

Catch live updates on coronavirus here

During the launch, Patanjali co-founder Baba Ramdev claimed that their clinical trial found that 69% of the patients tested recovered from COVID-19 within three days, while 100% of the patients recovered within a week, as per news agency ANI.

In his post, Acharya Balkrishna had announced that it is the first and foremost evidence-based ayurvedic medicine against the coronavirus contagion. Coronil has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Limited, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur, it claimed.

In a press release, Patanjali also said that it would disclose the results of the randomised clinical trials conducted on COVID-19 patients while controlling the placebo. It said that the trial was conducted by Patanjali Ayurvedic Medicines.

Earlier this month, ANI had quoted Acharya Balkrishna as saying that they had first conducted a simulation after which compounds that could fight the novel coronavirus were identified. He further said that they then conducted clinical trials on several patients who had tested positive for COVID-19 and the results were favourable. He had further said, according to ANI, that after taking their medicine, the patients recovered within five to 14 days, after which they tested negative for the disease.

Coronavirus-induced COVID-19 has caused a global pandemic, due to which the number of cases all over the world have reached nearly 90 lakh. In India itself, the cases as on Monday stood at 4.25 lakh, while the total number of deaths are over 13,000.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Direct supply of Covaxin to 18 states since May 1: Bharat Biotech
2Covid-19: Telangana announces 10-day lockdown from May 12  
3India conducting 18-20 lakh COVID tests a day: ICMR